| Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization D Maurel, L Comps-Agrar, C Brock, ML Rives, E Bourrier, MA Ayoub, ... Nature methods 5 (6), 561-567, 2008 | 567 | 2008 |
| Building a new conceptual framework for receptor heteromers S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ... Nature chemical biology 5 (3), 131-134, 2009 | 475 | 2009 |
| Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics M Manning, A Misicka, A Olma, K Bankowski, S Stoev, B Chini, T Durroux, ... Journal of neuroendocrinology 24 (4), 609-628, 2012 | 463 | 2012 |
| Structural bases of vasopressin/oxytocin receptor function. C Barberis, B Mouillac, T Durroux | 415 | 1998 |
| Oxytocin and vasopressin V1a and V2 receptors form constitutive homo-and heterodimers during biosynthesis S Terrillon, T Durroux, B Mouillac, A Breit, MA Ayoub, M Taulan, R Jockers, ... Molecular endocrinology 17 (4), 677-691, 2003 | 405 | 2003 |
| Time-resolved FRET between GPCR ligands reveals oligomers in native tissues L Albizu, M Cottet, M Kralikova, S Stoev, R Seyer, I Brabet, T Roux, ... Nature chemical biology 6 (8), 587-594, 2010 | 390 | 2010 |
| Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents M Manning, S Stoev, B Chini, T Durroux, B Mouillac, G Guillon Progress in brain research 170, 473-512, 2008 | 323 | 2008 |
| Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy R Rahmeh, M Damian, M Cottet, H Orcel, C Mendre, T Durroux, ... Proceedings of the National Academy of Sciences 109 (17), 6733-6738, 2012 | 226 | 2012 |
| A Fluorescent Ligand-Binding Alternative Using Tag-lite® Technology JM Zwier, T Roux, M Cottet, T Durroux, S Douzon, S Bdioui, N Gregor, ... Journal of biomolecular screening 15 (10), 1248-1259, 2010 | 149 | 2010 |
| D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1, 4, 5-tris phosphate to monitor G protein-coupled receptor activation E Trinquet, M Fink, H Bazin, F Grillet, F Maurin, E Bourrier, H Ansanay, ... Analytical biochemistry 358 (1), 126-135, 2006 | 145 | 2006 |
| Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding L Albizu, MN Balestre, C Breton, JP Pin, M Manning, B Mouillac, ... Molecular pharmacology 70 (5), 1783-1791, 2006 | 125 | 2006 |
| The oligomeric state sets GABAB receptor signalling efficacy L Comps‐Agrar, J Kniazeff, L Nørskov‐Lauritsen, D Maurel, M Gassmann, ... The EMBO journal 30 (12), 2336-2349, 2011 | 111 | 2011 |
| Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus F Jean-Alphonse, S Perkovska, MC Frantz, T Durroux, C Méjean, D Morin, ... Journal of the American Society of Nephrology 20 (10), 2190-2203, 2009 | 102 | 2009 |
| Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR T Durroux Trends in pharmacological sciences 26 (7), 376-384, 2005 | 97 | 2005 |
| Three components of the calcium current in cultured glomerulosa cells from rat adrenal gland. T Durroux, N Gallo‐Payet, MD Payet The Journal of physiology 404 (1), 713-729, 1988 | 88 | 1988 |
| BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues M Cottet, O Faklaris, D Maurel, P Scholler, E Doumazane, E Trinquet, ... Frontiers in endocrinology 3, 92, 2012 | 84 | 2012 |
| Molecular pharmacology of AVP and OT receptors and therapeutic potential C Barberis, D Morin, T Durroux, B Mouillac, G Guillon, R Seyer, M Hibert, ... Drug News & Perspectives 12 (5), 279, 1999 | 80 | 1999 |
| Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells D Moreno Delgado, TC Møller, J Ster, J Giraldo, D Maurel, X Rovira, ... Elife 6, e25233, 2017 | 78 | 2017 |
| Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding N Cotte, MN Balestre, A Aumelas, E Mahé, S Phalipou, D Morin, M Hibert, ... European Journal of Biochemistry 267 (13), 4253-4263, 2000 | 78 | 2000 |
| Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats V Fernández-Dueñas, JJ Taura, M Cottet, M Gómez-Soler, M López-Cano, ... Disease models & mechanisms 8 (1), 57-63, 2015 | 73 | 2015 |
